Advertisement
Heart, Lung and Circulation
Original Article| Volume 23, ISSUE 3, P287-292, March 2014

Iron Deficiency in Patients With Idiopathic Pulmonary Arterial Hypertension

Published:October 03, 2013DOI:https://doi.org/10.1016/j.hlc.2013.08.007

      Background

      Iron deficiency has been reported to be highly prevalent in idiopathic pulmonary arterial hypertension (iPAH) patients, with the potential to influence cardiac performance, pulmonary artery pressures and the pulmonary vascular response to hypoxia.

      Methods

      Iron status was evaluated in 29 iPAH patients, and was related to haemodynamic, echocardiographic and exercise parameters.

      Results

      Iron deficiency was present in 44.8% of all iPAH patients, although anaemia was only present in 13.8%. Iron-deficient patients had similar exercise capacity (6MWD: 446 ± 141 m), compared to iron-sufficient patients (421 ± 193 m), however 46.2% of iron deficient patients had NYHA FC 3 or higher, compared to 12.5% in non-iron deficient group. Additionally iron-deficient patients showed increased mean pulmonary arterial pressure (63.3 ± 12.2 mmHg; iron deficient vs. 38.8 ± 16.7 mmHg; non-iron deficient) and reduced cardiac index (1.3 ± 0.2 L/min/m2; iron deficient vs. 2.5 ± 0.4 L/min/m2; non-iron deficient).

      Conclusions

      Iron deficiency is highly prevalent in iPAH, and the extent of iron deficiency is related to haemodynamics and NYHA functional class. While the exact mechanism of iron deficiency is unknown, our study suggests that treatment of iron deficiency should be considered in iPAH patients.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart, Lung and Circulation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Galie N.
        • Hoeper M.M.
        • Humbert M.
        • Torbicki A.
        • Vachiery J.L.
        • Barbera J.A.
        • et al.
        Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).
        Eur Heart J. 2009; 30: 2493-2537
        • Rhodes C.J.
        • Howard L.S.
        • Busbridge M.
        • Ashby D.
        • Kondili E.
        • Gibbs J.S.
        • et al.
        Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights.
        J Am Coll Cardiol. 2011; 58: 300-309
        • Ruiter G.
        • Lankhorst S.
        • Boonstra A.
        • Postmus P.E.
        • Zweegman S.
        • Westerhof N.
        • et al.
        Iron deficiency is common in idiopathic pulmonary arterial hypertension.
        Eur Respir J. 2011; 37: 1386-1391
        • Smith T.G.
        • Talbot N.P.
        • Privat C.
        • Rivera-Ch M.
        • Nickol A.H.
        • Ratcliffe P.J.
        • et al.
        Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials.
        JAMA. 2009; 302: 1444-1450
        • Maeder M.T.
        • Khammy O.
        • dos Remedios C.
        • Kaye D.M.
        Myocardial and systemic iron depletion in heart failure implications for anemia accompanying heart failure.
        J Am Coll Cardiol. 2011; 58: 474-480
        • Gonzalez-Costello J.
        • Comin-Colet J.
        Iron deficiency and anaemia in heart failure: understanding the FAIR-HF trial.
        Eur J Heart Fail. 2010; 12: 1159-1162
        • Maurer M.S.
        • Teruya S.
        • Chakraborty B.
        • Helmke S.
        • Mancini D.
        Treating Anemia in Older Adults with Heart Failure with a Preserved Ejection Fraction (HFPEF) with epoetin alfa: single blind randomized clinical trial of safety and efficacy.
        Circ Heart Fail. 2013; 6: 254-263
        • Thomas C.
        • Thomas L.
        Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency.
        Clin Chem. 2002; 48: 1066-1076
        • Lang R.M.
        • Bierig M.
        • Devereux R.B.
        • Flachskampf F.A.
        • Foster E.
        • Pellikka P.A.
        • et al.
        Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.
        J Am Soc Echocardiogr. 2005; 18: 1440-1463
        • Nagueh S.F.
        • Appleton C.P.
        • Gillebert T.C.
        • Marino P.N.
        • Oh J.K.
        • Smiseth O.A.
        • et al.
        Recommendations for the evaluation of left ventricular diastolic function by echocardiography.
        Eur J Echocardiogr. 2009; 10: 165-193
        • Rhodes C.J.
        • Wharton J.
        • Howard L.
        • Gibbs J.S.
        • Vonk-Noordegraaf A.
        • Wilkins M.R.
        Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target.
        Eur Respir J. 2011; 38: 1453-1460
        • Cook J.D.
        • Dassenko S.
        • Skikne B.S.
        Serum transferrin receptor as an index of iron absorption.
        Br J Haematol. 1990; 75: 603-609
        • Westenbrink B.D.
        • Visser F.W.
        • Voors A.A.
        • Smilde T.D.
        • Lipsic E.
        • Navis G.
        • et al.
        Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well.
        Eur Heart J. 2007; 28: 166-171
        • Anker S.vH.S.
        Anaemia in chronic heart failure.
        International Medical Publishers, Bremen2009